ArticleJACC. Case reports2026
Cardiac Paraganglioma.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiac paragangliomas are rare neuroendocrine tumors that can present with catecholaminergic symptoms or be discovered incidentally. Multimodality imaging and genetic testing are central to diagnosis and management. CASE SUMMARY: A 76-year-old woman with paroxysmal atrial fibrillation and recurrent gastrointestinal bleeding underwent preprocedural imaging with cardiac computed tomography angiography for left atrial appendage occlusion, which revealed a large mass near the ascending aorta encasing the proximal right coronary artery. Surgical resection of the mass was performed. Histopathology confirmed the presence of paraganglioma. Genetic analysis identified a hereditary gene mutation. DISCUSSION: Cardiac paragangliomas are rare tumors that require a high index of suspicion. This case demonstrates the diagnostic value of advanced imaging in cardiac tumors and illustrates the role of genetic testing in identifying heritable paraganglioma syndromes. TAKE-HOME MESSAGES: Multimodality imaging is important in the diagnosis of cardiac masses. Surgical resection is the primary treatment for cardiac paragangliomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.